Compass Therapeutics Inc. (NASDAQ:CMPX) is a must-buy penny stock to buy now. On November 10, Pipe Sandler analyst Biren Amin reiterated that Compass Therapeutics Inc. (NASDAQ:CMPX) is a Buy and set a $12 price target. The positive stance stems from the company’s announcement that it has made significant progress in developing its clinical pipeline. Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development adriaticfoto/Shutterstock.com HC Wainwright analyst Joseph Pantginis ...